Turmeric is one of the most studied plants that exists today. Its medicinal properties and its components (mainly curcumin) have been the subject of more than 5600 biomedical studies reviewed and published. Given the considerable density of research carried out on this remarkable spice, it is not surprising that a growing number found that it can be favorably compared to a variety of conventional drugs, including: Tahor / Atorvastatin (a cholesterol drug): A 2008 study published in Drugs in R & D found that Turmeric’s Curcuminoid Basic Preparation Compared Favorably with Atorvastatin (Trade Name Tahor) on Endothelial Dysfunction, the Underlying Pathology of Blood Vessels That Causes Atherosclerosis, in Combination with Reduction of Inflammation and Oxidative Stress in patients with type 2 diabetes.
Corticosteroids (steroid drugs):
A 1999 study published in the journal Phytotherapy Research found that primary polyphenol in the turmeric spice, compared favorably to steroids in the management of chronic anterior uveitis, an inflammatory disease of the eye.
A 2008 study published in Critical Care Medicine concluded that curcumin compares favorably to corticosteroid dexamethasone drug in the animal model as an alternative therapy to protect lung transplantation associated with injuries produced by inflammatory genes. A previous 2003 study published in Cancer Letters found that it also compared favorably to dexamethasone in pulmonary ischemia / reperfusion injury.
Prozac / Fluoxetine & Imipramine (antidepressants):
A 2011 study published in the journal Acta Poloniae Pharmaceutica found that curcumin was comparable
Favorably to both drugs in the reduction of depressive behavior in an animal model.
This research has shown that turmeric extracts are effective in treating severe states of depression, and that the prozac turmeric combination is more effective than prozac, and that CurCuma is almost as effective as prozac.
A 1986 in vitro and ex vitro study published in the journal Arzneimittelforschung found that curcumin has antiplatelet and prostacyclin modulation effects that are comparable to aspirin, indicating that it may be of benefit in patients subject to venous thrombosis and requiring anti-arthritis treatment.
A 2004 study in the journal Oncogene found that curcumin (as well as resveratrol) are effective alternatives to certain drugs such as aspirin, ibuprofen, sulindac, phenylbutazone, naproxen, indomethacin, diclofenac, dexamethasone, celecoxib, and tamoxifen by exerting anti-inflammatory and antiproliferative activity against tumor cells.
Metformin (diabetes medicine)
A 2009 study published in the journal Biochemistry and Biophysical Community Research investigated how curcumin could be useful in the treatment of diabetes, finding that it activates AMPK (which increases glucose uptake) and suppresses expression of the glucogenesis gene (which suppresses glucose production in the liver) in hepatoma cells. Interestingly, they found that curcumin was 500 to 100,000 times (in the form known as tetrahydrocurcuminoids (THC)) more potent than metformin in activating AMPK and its target downstream acetyl-CoA carboxylas (ACC). Turmeric and its components also reveal their therapeutic properties in research on the resistance of cancers to several drugs.
Oxaliplatin (chemotherapy drug)
A 2007 study published in the International Journal of Cancer found that curcumin compares favorably with oxaliplatin as an antiproliferative agent in colorectal cell lines.
5600 biomedical and published peer-reviewed studies.
downloadable document Curcuma
Lipitor / atorvastatin (cholesterol drug) : [for more curcumin and ‘high cholesterol research’ –
Corticosteroids (steroid drugs): A 1999 study published in the journal Phytotherapy Research. [Ii] a 2008 study published in Critical Care Medicine. [iii] An earlier study published in 2003 in Cancer Letters [iv] [for more curcumin and inflammation research – 52 abstracts]
Prozac / Fluoxetine and Imipramine (Antidepressant): A 2011 study published in the journal Acta Poloniae Pharmaceutica [V] Curcumin and Depression
Aspirin (anticoagulant): In 1986, in vitro and ex vivo study published in the journal Arzneimittelforschung [vi] [for more curcumin and antiplatelet research]
Anti-inflammatory drugs : A 2004 study published in the journal Oncogene [vii] [additional for curcumin and anti-proliferative
Oxaliplatin (chemotherapy drug) : A 2007 study published in the International Journal of Cancer. [Viii] [for more curcumin and colorectal cancer
Metformin (diabetes medicine) : A 2009 study published in the journal Biochemitry and Community Research Biophysical. [Ix]